PD-Rx Pharmaceuticals, Inc. (PDRX)
USD 3.2
(-13.51%)
USD 3.2
(-13.51%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.78 Million | 3.23 Million | -465.77 Thousand | -586.53 Thousand | -283.87 Thousand | 421.89 Thousand |
| Net Income | -98.06 Thousand | 3.03 Million | 1.85 Million | -384.14 Thousand | -12.91 Thousand | 621.16 Thousand |
| Depreciation & Amortization | 139.05 Thousand | 126.88 Thousand | 114.63 Thousand | 161.02 Thousand | 177.32 Thousand | 176.54 Thousand |
| Deferred income taxes | - | - | -3955.00 | 75.72 Thousand | -58.73 Thousand | 37.44 Thousand |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 1.89 Million | 8274.00 | -1.74 Million | -406.01 Thousand | -482.08 Thousand | -395.15 Thousand |
| Other non-cash items | -149.88 Thousand | 66.22 Thousand | 1.12 Million | 406.44 Thousand | 1.01 Million | 809.69 Thousand |
| Investing Cash Flow | -426.84 Thousand | -502.7 Thousand | -85.92 Thousand | 700.26 Thousand | 2.6 Million | -484.68 Thousand |
| Investments in PPE | -426.84 Thousand | -550.2 Thousand | -107.92 Thousand | -49.74 Thousand | -145.72 Thousand | -274.38 Thousand |
| Acquisitions | - | - | 22 Thousand | - | 1470.00 | 39.75 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | 47.5 Thousand | 22 Thousand | 750 Thousand | 2.75 Million | -250.04 Thousand |
| Financing Cash Flow | -710.00 | -165.2 Thousand | - | 933.7 Thousand | -3.77 Million | -1.16 Million |
| Debt repayment | - | - | - | -933.7 Thousand | - | - |
| Dividends payments | - | - | - | - | -3.77 Million | -1.13 Million |
| Common Stock Repurchased | -710.00 | -165.2 Thousand | - | - | - | -29.04 Thousand |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | 1.72 Million | -834.23 Thousand | -1.84 Million | 271.59 Thousand | 10.91 Thousand | -970.62 Thousand |
| Accounts payables | - | - | 1.06 Million | -5655.00 | -293.58 Thousand | 470.03 Thousand |
| Inventory | 196.18 Thousand | 815.39 Thousand | -802.92 Thousand | -383.45 Thousand | -280.14 Thousand | 25.87 Thousand |
| Other working capital | -27.04 Thousand | 27.11 Thousand | -155.29 Thousand | -288.49 Thousand | 80.72 Thousand | 79.56 Thousand |
| Cash at beginning of period | 5.47 Million | 2.9 Million | 3.45 Million | 2.4 Million | 3.86 Million | 5.08 Million |
| Cash at end of period | 6.83 Million | 5.47 Million | 2.9 Million | 3.45 Million | 2.4 Million | 3.86 Million |
| Capital Expenditure | -426.84 Thousand | -550.2 Thousand | -107.92 Thousand | -49.74 Thousand | -145.72 Thousand | -274.38 Thousand |
| Effect of forex changes on cash | - | - | - | -1.04 Million | 1.44 Million | - |
| Net cash flow / Change in cash | 1.36 Million | 2.56 Million | -551.7 Thousand | 1.04 Million | -1.45 Million | -1.22 Million |
| Free Cash Flow | 1.36 Million | 2.68 Million | -573.7 Thousand | -636.27 Thousand | -429.6 Thousand | 147.51 Thousand |
| Breakdown | 2022 FY | 2021 FY | 2020 FY | 2019 FY | 2018 FY | 2017 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -98.06 Thousand | 3.03 Million | 1.85 Million | -384.14 Thousand | -12.91 Thousand | 621.16 Thousand |
| Depreciation & Amortization | 139.05 Thousand | 126.88 Thousand | 114.63 Thousand | 161.02 Thousand | 177.32 Thousand | 176.54 Thousand |
| Deferred income taxes | - | - | -3955.00 | 75.72 Thousand | -58.73 Thousand | 37.44 Thousand |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 1.89 Million | 8274.00 | -1.74 Million | -406.01 Thousand | -482.08 Thousand | -395.15 Thousand |
| Other non-cash items | -149.88 Thousand | 66.22 Thousand | 1.12 Million | 406.44 Thousand | 1.01 Million | 809.69 Thousand |
| Investing Cash Flow | -426.84 Thousand | -502.7 Thousand | -85.92 Thousand | 700.26 Thousand | 2.6 Million | -484.68 Thousand |
| Investments in PPE | -426.84 Thousand | -550.2 Thousand | -107.92 Thousand | -49.74 Thousand | -145.72 Thousand | -274.38 Thousand |
| Acquisitions | - | - | 22 Thousand | - | 1470.00 | 39.75 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | 47.5 Thousand | 22 Thousand | 750 Thousand | 2.75 Million | -250.04 Thousand |
| Financing Cash Flow | -710.00 | -165.2 Thousand | - | 933.7 Thousand | -3.77 Million | -1.16 Million |
| Debt repayment | - | - | - | -933.7 Thousand | - | - |
| Dividends payments | - | - | - | - | -3.77 Million | -1.13 Million |
| Common Stock Repurchased | -710.00 | -165.2 Thousand | - | - | - | -29.04 Thousand |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | 1.72 Million | -834.23 Thousand | -1.84 Million | 271.59 Thousand | 10.91 Thousand | -970.62 Thousand |
| Accounts payables | - | - | 1.06 Million | -5655.00 | -293.58 Thousand | 470.03 Thousand |
| Inventory | 196.18 Thousand | 815.39 Thousand | -802.92 Thousand | -383.45 Thousand | -280.14 Thousand | 25.87 Thousand |
| Other working capital | -27.04 Thousand | 27.11 Thousand | -155.29 Thousand | -288.49 Thousand | 80.72 Thousand | 79.56 Thousand |
| Cash at beginning of period | 5.47 Million | 2.9 Million | 3.45 Million | 2.4 Million | 3.86 Million | 5.08 Million |
| Cash at end of period | 6.83 Million | 5.47 Million | 2.9 Million | 3.45 Million | 2.4 Million | 3.86 Million |
| Capital Expenditure | -426.84 Thousand | -550.2 Thousand | -107.92 Thousand | -49.74 Thousand | -145.72 Thousand | -274.38 Thousand |
| Effect of forex changes on cash | - | - | - | -1.04 Million | 1.44 Million | - |
| Net cash flow / Change in cash | 1.36 Million | 2.56 Million | -551.7 Thousand | 1.04 Million | -1.45 Million | -1.22 Million |
| Free Cash Flow | 1.36 Million | 2.68 Million | -573.7 Thousand | -636.27 Thousand | -429.6 Thousand | 147.51 Thousand |
ACAD
NETLINK
CRI
0230
002938
TRN